New Jersey Law Journal names Parvin K. Aminolroaya among the “Top Women in Law”

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.” “I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the […]

October 23, 2020

Parvin Aminolroya

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.”

“I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the District of New Jersey.

A litigator at Seeger Weiss for more than a decade, Aminolroaya has brought her extensive background in class action consumer and mass tort matters to bear on many of the biggest cases before the country. Her work includes serving in key trial, discovery, and expert development roles, including discovery negotiations, depositions, expert development, brief writing, and trial preparation. She has represented a wide spectrum of plaintiffs in such significant matters as litigation against makers of opioid drugs, representing counties and municipalities whose health and hospital systems have been severely tested by the epidemic of drug abuse; litigation against 3M over allegations that the manufacturer sold defective earplugs both to the military for use in battle situations and to civilians for high noise exposure situations; and litigation against Volkswagen and other carmakers for disguising the actual emission levels of their diesel engine cars, resulting several multi-billion dollar settlements; among others.

“I find my work so meaningful,” Aminolroaya says. “Cases like In re National Prescription Opiate Litigation seek to recover funds for state and local governments addressing the harm to their communities caused by defendants’ conduct. It’s work that impacts entire country.”

New Jersey Law Journal will be publishing a special supplement later this year that will spotlight the honorees, their accomplishments, and their insights. New Jersey Law Journal last published a “Top Women in Law” feature in 2018.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction.

Related News

May 24, 2024
Lawdragon Names Nine Seeger Weiss Partners to 500 Plaintiff Financial Lawyers List

Seeger Weiss is proud to announce that Lawdragon recognized nine partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Jennifer Scullion, Chris Ayers, Ben Barnett, Parvin Aminolroaya, and Steve Daroci — on the 2024 500 Leading Plaintiff Financial Lawyers list. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the […]

Read More
May 13, 2024
Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

Read More
May 9, 2024
Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

Read More